Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “MedRegen, LLC”

6 pharma patents match "MedRegen, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "MedRegen, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “MedRegen, LLC” · 30,257 patents in full index Clear search

  1. US 12115149

    Formulations, methods, kits, and dosage forms

    MedRegen, LLC · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  2. US 12048687

    Methods of recruiting SDF-producing macrophages

    MedRegen, LLC · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  3. US 11291657

    Methods of treating inflammatory bowel disease with AMD3100 and Tacrolimus

    MedRegen, LLC · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted
  4. US 10945993

    Methods of recruiting SDF-producing macrophages

    MedRegen, LLC · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  5. US 10813917

    Treatment methods utilizing stem cell mobilizers and immunosuppressive agents

    MedRegen, LLC · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  6. US 10420751

    Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus

    MedRegen, LLC · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted